UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 425

Sortiert nach

Reply to: Temporary Like Achilles: Pre‐emptive germline pharmacogenetic testing

Basic & clinical pharmacology & toxicology, 2023-10, Vol.133 (4), p.400-401

2023

Link zum Volltext

Verfügbarkeit prüfen

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

Clinical and translational science, 2020-01, Vol.13 (1), p.116-124

2020

Link zum Volltext

Verfügbarkeit prüfen

Liposomal drug formulations in cancer therapy: 15 years along the road

Drug discovery today, 2012-02, Vol.17 (3-4), p.160-166

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

Clinical pharmacology and therapeutics, 2018-05, Vol.103 (5), p.770-777

2018

Link zum Volltext

Verfügbarkeit prüfen

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines

European journal of human genetics : EJHG, 2020-04, Vol.28 (4), p.508-517

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Clinical pharmacology and therapeutics, 2019-10, Vol.106 (4), p.866-873

2019

Link zum Volltext

Verfügbarkeit prüfen

Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

Clinical pharmacology and therapeutics, 2021-03, Vol.109 (3), p.591-604

2021

Link zum Volltext

Verfügbarkeit prüfen

Liver and kidney function in patients with Covid‐19 treated with remdesivir

British journal of clinical pharmacology, 2021-11, Vol.87 (11), p.4450-4454

2021

Link zum Volltext

Verfügbarkeit prüfen

Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

European journal of cancer (1990), 2020-12, Vol.141, p.9-20

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacokinetics of tyrosine kinase inhibitors

Cancer treatment reviews, 2009-12, Vol.35 (8), p.692-706

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics, a novel section in the European Journal of Human Genetics

European journal of human genetics : EJHG, 2018-10, Vol.26 (10), p.1399-1400

Guchelaar, Henk-Jan

2018

Link zum Volltext

Verfügbarkeit prüfen

Estimating the potential impact of implementing pre‐emptive pharmacogenetic testing in primary care across the UK

British journal of clinical pharmacology, 2021-07, Vol.87 (7), p.2907-2925

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device

British journal of clinical pharmacology, 2018-12, Vol.84 (12), p.2889-2902

2018

Link zum Volltext

Verfügbarkeit prüfen

A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors

CPT: pharmacometrics and systems pharmacology, 2019-10, Vol.8 (10), p.720-737

2019

Link zum Volltext

Verfügbarkeit prüfen

The PREPARE study: benefits of pharmacogenetic testing are unclear – Authors' reply

The Lancet (British edition), 2023-06, Vol.401 (10391), p.1851-1852

2023

Link zum Volltext

Verfügbarkeit prüfen

Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

British journal of clinical pharmacology, 2023-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

Journal of clinical medicine, 2020-09, Vol.9 (9), p.2890

2020

Link zum Volltext

Verfügbarkeit prüfen

A Genome‐Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early‐Stage Breast Cancer Patients

Clinical pharmacology and therapeutics, 2024-07, Vol.116 (1), p.155-164

2024

Link zum Volltext

Verfügbarkeit prüfen

Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy

Clinical pharmacology and therapeutics, 2024-06, Vol.115 (6), p.1282-1292

2024

Link zum Volltext

Verfügbarkeit prüfen

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

European journal of clinical pharmacology, 2017-10, Vol.73 (10), p.1247-1252

2017

Link zum Volltext

Verfügbarkeit prüfen

Self‐management support with the Respiratory Adherence Care Enhancer instrument in asthma and chronic obstructive pulmonary disease: An implementation trial

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1344-1356

2024

Link zum Volltext

Verfügbarkeit prüfen

Detecting DPD deficiency: when perfect is the enemy of good

Cancer chemotherapy and pharmacology, 2021-05, Vol.87 (5), p.717-719

2021

Link zum Volltext

Verfügbarkeit prüfen

An Electronic Health Record Text Mining Tool to Collect Real‐World Drug Treatment Outcomes: A Validation Study in Patients With Metastatic Renal Cell Carcinoma

Clinical pharmacology and therapeutics, 2020-09, Vol.108 (3), p.644-652

2020

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study

Journal of clinical oncology, 2019-03, Vol.37 (8), p.636-646

2019

Link zum Volltext

Verfügbarkeit prüfen

Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics

Clinical pharmacology and therapeutics, 2020-03, Vol.107 (3), p.617-627

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 425

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(400)
Mit Volltextzugriff
(392)

Publikationsform

Artikel
(423)
Berichte
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Reply to: Temporary Like Achilles: Pre‐emptive germline pharmacogenetic testing

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

Liposomal drug formulations in cancer therapy: 15 years along the road

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

Liver and kidney function in patients with Covid‐19 treated with remdesivir

Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

Clinical pharmacokinetics of tyrosine kinase inhibitors

Pharmacogenomics, a novel section in the European Journal of Human Genetics

Estimating the potential impact of implementing pre‐emptive pharmacogenetic testing in primary care across the UK

Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device

A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors

The PREPARE study: benefits of pharmacogenetic testing are unclear – Authors' reply

Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

A Genome‐Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early‐Stage Breast Cancer Patients

Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

Self‐management support with the Respiratory Adherence Care Enhancer instrument in asthma and chronic obstructive pulmonary disease: An implementation trial

Detecting DPD deficiency: when perfect is the enemy of good

An Electronic Health Record Text Mining Tool to Collect Real‐World Drug Treatment Outcomes: A Validation Study in Patients With Metastatic Renal Cell Carcinoma

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study

Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics

Suchergebnisse filtern